As one of 14 presenting companies, each organization will have the opportunity to introduce its business plan and technology to venture capitalists and investors that represent almost $3 billion in investment potential. An impressive 47 companies from around the Southeast submitted applications to present at the conference.
The companies were chosen by a committee of investors, development professionals and medical device industry leaders from across the Southeast. SEMDA’s presenting company committee was led by Tom Brooks, partner, HealthCare Capital Partners; Tom Callaway, managing director, Georgia Venture Capital; and Gerard van Hamel Platerink, managing director, Accuitive Medical Ventures.
“SEMDA’s Investor Conference is a great opportunity for investors to see the most promising early to mid-stage medical device companies in the Southeast,” said Tom Callaway, managing director of Georgia Venture Partners. “Of even greater value, however, is the networking among fellow investors interested in the medical device industry in our region.”
Presenting companies include:
AqueSys, Inc.
AxoGen, Inc.
Biowatch Medical, Inc.
DigitalVision Systems, LLC
Icon Interventional Systems, Inc.
OptiVia Medicalv
Pathfinder Therapeutics, Inc.
SoloHealth, LLC
SpherIngenics, Inc.
TransCardiac Therapeutics, LLC
VG Innovations, LLC
Visioneering Corporation
Zassi Medical Evolutions, Inc.
Zenda Technologies, Inc.
For more information and registration, please visit the SEMDA Investor Conference website at http://www.semda.net/conference.
About SEMDA Created in 2004, the Southeastern Medical Device Association (SEMDA) is a non-profit trade association that supports and promotes medical device companies in the Southeast. The association provides a unique resource and networking opportunity for medical device companies, inventors, physicians, and investors interested in accelerating the growth of the medical device industry in the Southeast. For more information, visit http://www.semda.net.
